Cardiac imaging using nuclear medicine and postitron emission tomography

Radiologic Clinics of North America

Volumn 42, Issue 3, 2004, Pages 619-634

  Crean, Andrew ^a   Dutka, David ^b   Coulden, Richard ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; ELECTROCARDIOGRAM; EXERCISE TEST; GAMMA RADIATION; HEART EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; HUMAN; IMAGING SYSTEM; MEDICAL AUDIT; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE VENTRICULOGRAPHY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HEART DISEASES; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 2942544405     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2004.03.002     Document Type: Review

References (65)

1. Coyne E., Belvedere D., Vande Streer P. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol. 17:1991;1289-1294
2. White C., Stone D.L., Coulden R.A. Does pharmacological stress in myocardial perfusion imaging need medical supervision? Nucl Med Commun. 21:2000;395
3. Beharry N., White C., Stone D.L., et al. Non-medical supervision of pharmacological stress myocardial perfusion imaging. Nucl Med Commun. 24:2003;335-336
4. Wackers F.J.T., Berman D.S., Maddahi J. Technetium-99m hexacis 2-methoxyosobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 30:1989;1989-1995
5. Gibson P., Demus D., Noto R., Hudson B., Johnson L. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol. 39:2002;999-1004
6. Santana C., Garcia E., Vansant E., Krawczynska E., Folks R., Cooke C., et al. Gated stress-only technetium 99m myocardial perfusion SPECT imaging accurately assesses coronary artery disease. Nucl Med Commun. 24:2003;241-249
7. Candell-Riera J., Santana-Boado C., Bermejo B. Interhospital observer agreement in interpretation of exercise myocardial Tc-99m-tetrofosmin SPECT studies. J Nucl Cardiol. 8:2001;49-57
8. Cerqueira M., Weissman N., Dilsizian V. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 105:2002;539-542
9. Weiss A., Maddahi J., Lew A. Reverse redistribution of thallium-201: a sign of non-transmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol. 7:1986;61-67
10. Araujo W., DePuey E., Kamran M. Artefactual reverse redistribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi. J Nucl Cardiol. 7:2000;633-638
11. DePuey E. How to detect and avoid myocardial perfusion SPECT artefacts. J Nucl Med. 53:1994;699-702
12. Lette J., Lapoint J., Waters D., et al. Transient left ventricular cavity dilatation during diprydamole-thallium imaging as an indicator of severe coronary disease. Am J Cardiol. 66:1990;1163-1169
13. Germano G., Kiat H., Kavanagh P.B. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 36:1995;2138-2147
14. Taillefer R., DePuey E., Udelson J. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 29:1997;69-77
15. Choi J., Lee K., Kim S. Gating provides improved accuracy for differentiating artefacts from true lesions in equivocal fixed defects on technetium 99m tetrofosmin perfusion SPECT. J Nucl Cardiol. 5:1998;395-401
16. Smanio P., Watson D., Segalla D. Value of gating of technetium 99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol. 30:1997;1687-1692
17. Sharir T., Germano G., Kavanagh P. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 100:1999;1035-1042
18. Sharir T., Germano G., Kang X. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischaemia and the post-stress ejection fraction. J Nucl Med. 42:2001;831-837
19. Jones R., Johnson S., Bigelow C. Exercise radionuclide angiography predicts cardiac death in patients with coronary artery disease. Circulation. 84:1991;152-158
20. Morris K., Palmeri S., Califf R. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol. 55:1985;318-324
21. Lang T.F., Hasegawa B.H., Liew S.C., et al. Description of emission-transmission computed tomography imaging system. J Nucl Med. 33:1992;1881-1886
22. Ficaro E., Fessler J., Shreve P. Simultaneous transmission/emission myocardial perfusion tomography: diagnostic accuracy of attenuation-corrected 99m-technetium sestamibi single-photon emission computed tomography. Circulation. 93:1996;463-473
23. Hendel R., Berman D., Cullom S. Multicentre clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation. 99:1999;2742-2749
24. Links J., Becker L., Rigo P., Taillefer R., Hanelin L., Anstett F. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicentre trial. J Nucl Cardiol. 7:2000;414-425
25. King M.A., Tsui B.M.W., Pan T.S. Attenuation compensation for cardiac SPECT imaging: Part 1. Impact of attenuation and methods estimating attenuation maps. J Nucl Cardiol. 2:1995;513-520
26. King M.A., Tsui B.M.W., Pan T.S. Attenuation compensation for cardiac SPECT imaging: Part 2. Attenuation compensation algorithms. J Nucl Cardiol. 3:1995;55-65
27. Wackers F. Attenuation compensation of cardiac SPECT: a critical look at a confusing world. J Nucl Cardiol. 9:2002;438-440
28. O'Connor M., Kemp B. A multicentre evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. J Nucl Cardiol. 9:2002;361-376
29. Hendel R., Corbet J., Cullom S., et al. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol. 9:2002;135-143
30. Anagnostopoulous C., Harbinson M., Kelion A., et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart. 90:2004;1-10
31. Braunwald E., Kloner R.A. The stunned myocardium: prolonged post ischaemic ventricular dysfunction. Circulation. 66:1982;1146-1149
32. Vanoverschelde J.L., Wijns W., Borgers M., et al. Chronic myocardial hibernation in humans: from bench to bedside. Circulation. 95:1997;1961-1969
33. Rahimtoola S. The hibernating myocardium. Am Heart J. 117:1989;211-221
34. Fallavollita J., Canty J. Differential 18-F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion. Circulation. 99:1999;2798-2805
35. Shen Y., Vatner S. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning? Circ Res. 76:1995;479-488
36. Ausma J., Schaart G., Thone F. Chronic ischaemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol. 4:1995;29-37
37. Schwarz E., Schoendube F., Kostin S. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularisation. J Am Coll Cardiol. 31:1998;1018-1026
38. Allman K., Shaw L., Hachamovitch R. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 39:2002;1151-1158
39. Bax J., Wijns W., Cornel J. Accuracy of currently available techniques for prediction of functional recovery after revascularisation in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 30:1997;1451-1460
40. Kim R., Wu E., Rafael A. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453
41. Jain D., Zraet B.L. Nuclear imaging techniques for the assessment of myocardial viability. Cardiol Clin. 13:1995;43-58
42. Dilsizian V., Rocco T., Freedman N. Enhanced detection of ischaemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146
43. Kiat H., Berman D., Maddahi J. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 12:1988;1456-1463
44. Gonzalez P., Massardo T., Munoz A., et al. Is the addition of ECG gating to technetium-99m sestamibi SPECT of value in the assessment of myocardial viability? An evaluation based on 2 dimensional echocardiography following re-vascularisation. Eur J Nucl Med. 23:1996;1315-1321
45. Marcassa C., Galli M., Cuocolo A., et al. Rest redistribution thallium-201 rest technetium-99m sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction. J Nucl Med. 38:1997;419-425
46. Maes A., Borgers M., Flameng W. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol. 29:1997;62-68
47. Medrano R., Lowry R., Young J. Assessment of myocardial viability with 99m Tc sestamibi in patients undergoing cardiac transplantation: a scintigraphic/pathological study. Circulation. 94:1996;1010-1017
48. Ragosta M., Beller G., Watson D. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary artery bypass in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641
49. Shelbert H.R. Merits and limitations to viability and future developments. J Nucl Cardiol. 1:1994;S86
50. Tamaki N., Yonekura Y., Senda M., et al. Value and limitation of stress thallium-201 single photon emission computed tomography: comparison with nitrogen-13 ammonia positron tomography. J Nucl Med. 29:1988;1181-1188
51. Go R., Marwick T., MacIntyre W. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilising a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 31:1990;1899-1905
52. Stewart R., Schwaiger M., Molina E. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for the detection of coronary artery disease. Am J Cardiol. 67:1991;1303-1310
53. Bacharach S., Bax J., Case J., Delbeke D., Kurdziel K., Martin W., et al. PET myocardial glucose metabolism and perfusion imaging: American Society of Nuclear Cardiology Practice Guidelines. J Nucl Cardiol. 10:2003;543-554
54. DeFronzo R., Tobin J., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E223
55. Dutka D., Camici P. The contribution of positron emission tomography to the study of ischaemic heart failure. Prog Cardiovasc Dis. 43:2001;399-418
56. Stoll H.P., Hellwig N., Alexander C., et al. Myocardial metabolism imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual isotope single-photon emission tomography. Eur J Nucl Med. 21:1994;1085-1092
57. Di Carli M., Asgarzadie F., Schelbert H., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischaemic cardiomyopathy. Circulation. 92:1995;3436-3444
58. Yusuf S., Flather M., Pogue J., et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 352:1998;507-514
59. Aude Y., Garza L. How to prevent unnecessary coronary interventions: identify lesions responsible for ischaemia in the cath lab. Curr Opin Cardiol. 18:2003;394-399
60. Yanagisawa H., Chikamori T., Tanaka N., et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J. 66:2002;1105-1109
61. Groutars R.G., Versijlbergen J.F., Muller A.J., et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium-99m tetrofosmin dual isotope myocardial SPECT. J Nucl Cardiol. 7:2000;333-341
62. Berman D., Hachamovitch R., Kiat H., et al. Incremental value of prognostic testing in patients with known or suspected ischaemic heart disease: a basis for optimal utilisation of exercise technetium-99m sestamibi myocardial perfusion single photon emission computed tomography. J Am Coll Cardiol. 26:1995;639-647
63. Mishra J.P., Acio E., Heo J., et al. Impact of stress single photon emission computed tomography perfusion imaging on down stream resource allocation. Am J Cardiol. 83:1999;1401-1403
64. Shaw L.J., Hachamovitch R., Berman D.S., et al. The economic consequences of available diagnostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischaemia. J Am Coll Cardiol. 33:1999;661-669
65. Patterson R., Eisner R., Horowitz S. Comparison of cost-effectiveness and utility of exercise. ECG, single photon emission computed tomoraphy, positron emission tomography and coronary angiography for the diagnosis of coronary artery disease. Circulation. 91:1995;54-65